SLC2A3 and colorectal carcinoma: We also showed that higher levels of METTL14, miR‐6769b‐3p, and miR‐499a‐3p predicted a better prognosis, but the elevated expression of SLC2A3 and PGAM1 exhibited robustly shorter OS in patients with p53‐WT CRC (Fig 6F and Appendix Fig S8A).